AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $253.35
-
Support level$216.07
-
Resistance levelN/A
-
Beta0.2
-
RSI (14-day)71.8
- ABBV is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- ABBV is one of this month's top performers with a return of 15.9 percent, beating 90 percent of stocks in the S&P-100.
- Up 17.0 percent, ABBV is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $182.31 | $253.35 | 100.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $221.26 | $214.78 | $225.96 | $230.57 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.1%
-
In the next month13.8%
-
In the next year50.2%
| Period | Value |
|---|---|
| Historical (5 year) | 23.4% |
| Last month | 20.8% |
| Current estimate | 26.0% |
| Next month forecast | 24.4% |